Add to ORKGPopulation pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currentl
BACKGROUND Among the various forms of TB, tuberculous meningitis (TBM) is the most severe, with abo...
Background Current TB treatment for children is not optimized to provide adequate drug levels in TB ...
Background: Current guidelines for dosing of anti-TB drugs in children advocate higher doses for rif...
Aims Pharmacokinetic studies in the past have shown inadequate antituberculosis drug levels in child...
The World Health Organization (WHO) recently issued revised first-line antituberculosis (anti-TB) dr...
Among the various forms of TB, tuberculous meningitis (TBM) is the most severe, with about 30 % mort...
OBJECTIVE: To assess the pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyraz...
Tuberculosis (TB) is among the top 10 causes of death among children worldwide. Recent reports sugg...
Optimal doses of first-line drugs for treatment of drug-susceptible tuberculosis in children and you...
The main problem for treatment of children with various manifestations of tuberculosis is the lack o...
INTRODUCTION: Despite its longstanding role in tuberculosis (TB) treatment, there continues to be em...
This work aimed to evaluate the once-daily antituberculosis treatment as recommended by the new Indi...
Abstract Background Low plasma levels of first-line antitubercular drugs can be counted among the ma...
AIMS Low rifampicin plasma concentrations can lead to treatment failure and increased risk of devel...
This work aimed to evaluate the once‐daily antituberculosis treatment as recommended by the new Indi...
BACKGROUND Among the various forms of TB, tuberculous meningitis (TBM) is the most severe, with abo...
Background Current TB treatment for children is not optimized to provide adequate drug levels in TB ...
Background: Current guidelines for dosing of anti-TB drugs in children advocate higher doses for rif...
Aims Pharmacokinetic studies in the past have shown inadequate antituberculosis drug levels in child...
The World Health Organization (WHO) recently issued revised first-line antituberculosis (anti-TB) dr...
Among the various forms of TB, tuberculous meningitis (TBM) is the most severe, with about 30 % mort...
OBJECTIVE: To assess the pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyraz...
Tuberculosis (TB) is among the top 10 causes of death among children worldwide. Recent reports sugg...
Optimal doses of first-line drugs for treatment of drug-susceptible tuberculosis in children and you...
The main problem for treatment of children with various manifestations of tuberculosis is the lack o...
INTRODUCTION: Despite its longstanding role in tuberculosis (TB) treatment, there continues to be em...
This work aimed to evaluate the once-daily antituberculosis treatment as recommended by the new Indi...
Abstract Background Low plasma levels of first-line antitubercular drugs can be counted among the ma...
AIMS Low rifampicin plasma concentrations can lead to treatment failure and increased risk of devel...
This work aimed to evaluate the once‐daily antituberculosis treatment as recommended by the new Indi...
BACKGROUND Among the various forms of TB, tuberculous meningitis (TBM) is the most severe, with abo...
Background Current TB treatment for children is not optimized to provide adequate drug levels in TB ...
Background: Current guidelines for dosing of anti-TB drugs in children advocate higher doses for rif...